Laboratory variables as predictors of progression in gastroenteropancreatic neuroendocrine tumors in different lines of antineoplastic treatments.
Daniela Pezzutti Domigues ArmentanoMariana Ribeiro MonteiroPedro Nazareth AguiarJessica Sayuri TsukamotoRaquel Baptista PioRenata Eliane DE ÁvilaRaphael Leonardo Cunha de AraujoPedro Luiz Serrano UsÓn JuniorPublished in: Einstein (Sao Paulo, Brazil) (2022)
Chromogranin A, neutrophils and platelets-to-lymphocyte ratio were associated with disease progression during systemic treatment in gastroenteropancreatic neuroendocrine tumors. Further prospective studies with larger cohorts are necessary to validate our findings.